Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis

Efficacy of conventional chemoimmunotherapy is limited in patients with Richter syndrome (RS) with anticipated median overall survival (OS) of less than 10 months. Allogeneic hematopoietic cell transplantation (allo-HCT) is commonly offered as a consolidative treatment option in RS. To our knowledge...

Descripción completa

Detalles Bibliográficos
Autores principales: Aulakh, Sonikpreet, Reljic, Tea, Yassine, Farah, Ayala, Ernesto, Chavez, Julio C., Chanan-Khan, Asher, Pinilla-Ibarz, Javier, Kumar, Ambuj, Kharfan-Dabaja, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666647/
https://www.ncbi.nlm.nih.gov/pubmed/32473105
http://dx.doi.org/10.1016/j.hemonc.2020.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666647/
https://www.ncbi.nlm.nih.gov/pubmed/32473105
http://dx.doi.org/10.1016/j.hemonc.2020.05.002

Ejemplares similares